tm logo
CONJUALL
Live/Registered
REGISTERED

on 20 Aug 2024

Last Applicant/ Owned by

8-26, Munpyeongseo-ro, Daedeok-gu

Daejeon

KR

34302

Serial Number

97191384 filed on 27th Dec 2021

Registration Number

7477524 registered on 20th Aug 2024

in the Principal Register

Correspondent Address

Corey K. Cho

Corey K. Cho Saliwanchik, Lloyd & Eisenschenk, P.A.

Gainesville, FL 32608

United States

Filing Basis

No Filing Basis

Disclaimer

NO DATA

CONJUALL

Scientific study and research in the field(s) of research on the subject of pharmaceuticals; development of pharmaceutical preparations and medicines; medical and pharmaceutical research services; biological research and analysis; chemical research and analysis; biochemical research and analysis; and scientific research in the nature of conducting clinical trials for others Medicinal preparations Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Scientific study and research in the field(s) of research on the subject of pharmaceuticals; development of pharmaceutical preparations and medicines; medical and pharmaceutical research services; biological research and analysis; chemical research and analysis; biochemical research and analysis; and scientific research in the nature of conducting clinical trials for others


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Medicinal preparations for prevention and treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases, namely, antibodies, antibody conjugates and active ingredients and antibody conjugates; chemical reagents for medical use, especially chemical reagents for linking molecules for medical use; colostral antibodies and the chemical modifications and conjugates thereof for medical purposes and medical laboratory tests; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biological preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; Chemical preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical pharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical molecular diagnostic reagents for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biopharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical preparations for treatment of rare diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97191384

Mark Type

No Service Mark

Attorney Docket Number

No TWL.ITU1T

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
20th Aug 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
20th Aug 2024REGISTERED-PRINCIPAL REGISTER
04th Jun 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04th Jun 2024PUBLISHED FOR OPPOSITION
15th May 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02th May 2024TEAS/EMAIL CORRESPONDENCE ENTERED
02th May 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
02th May 2024ASSIGNED TO LIE
02th May 2024APPROVED FOR PUB - PRINCIPAL REGISTER
12th Dec 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED